low contrast letter acuity
Showing 1 - 25 of >10,000
Low Vision Trial in Ghent (Scleral contact lens without a passive artificial iris, Scleral contact lens with a passive
Terminated
- Low Vision
- Scleral contact lens without a passive artificial iris
- +3 more
-
Ghent, BelgiumUniversity Hospital Ghent (UZGent)
Apr 19, 2022
Meibomian Gland Dysfunction Trial in San Antonio (Meibomian gland (MG) expression)
Not yet recruiting
- Meibomian Gland Dysfunction
- Meibomian gland (MG) expression
-
San Antonio, TexasUniversity of the Incarnate Word Rosenberg School of Optometry
Feb 1, 2023
Relapsing Remitting Multiple Sclerosis, Optic Neuropathy, Optic; Neuritis, With Demyelination Trial in Australia, Canada, United
Terminated
- Relapsing Remitting Multiple Sclerosis
- +2 more
- CNM-Au8
- Placebo
-
Dallas, Texas
- +6 more
Aug 10, 2022
Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)
Not yet recruiting
- Relapsing Remitting Multiple Sclerosis
- PIPE-307 Dose A
- +2 more
- (no location specified)
Oct 9, 2023
Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)
Not yet recruiting
- Age Related Macular Degeneration (AMD)
- SPIN
- Non-aerobic, stretching/balance intervention Control
-
Decatur, GeorgiaAtlanta VA Medical and Rehab Center, Decatur, GA
Jun 26, 2023
Multiple Sclerosis Trial in Aurora, Philadelphia (ACTHAR Gel (ACTH), IV methylprednisolone (steroids))
Terminated
- Multiple Sclerosis
- ACTHAR Gel (ACTH)
- IV methylprednisolone (steroids)
-
Aurora, Colorado
- +1 more
Feb 24, 2022
ODYSight in Management of patientS With imparairEd Visual
Active, not recruiting
- Impaired Visual Acuity
- OdySight
-
Chambéry, Auvergne Rhône Alpes, France
- +7 more
Oct 4, 2023
Visual Parameters by Visual Evoked Potentials Captured by EEG
Recruiting
- Visual Neurosciences
- 68-electrode electroencephalography with steady state visual evoked potentials
-
Woluwe-Saint-Lambert, Bruxelles, BelgiumInstitute Of NeuroSciences
Jan 6, 2023
Natural History of Optic Neuritis
Completed
- Multiple Sclerosis
-
Bethesda, Maryland
- +2 more
Aug 24, 2022
" Visual Characterization of Parkinson's Patients and Oculomotor
Not yet recruiting
- Parkinson Disease
- Clinical measurements
- Oculomotor or perceptual therapy
- (no location specified)
Sep 13, 2023
Optic Neuritis, Optic; Neuritis, With Demyelination Trial in Paris (ACT-01 IV administration, Placebo IV administration)
Recruiting
- Optic Neuritis
- Optic; Neuritis, With Demyelination
- ACT-01 IV administration
- Placebo IV administration
-
Paris, FranceCIC Neurosciences - La Pitié Salpêtrière
Feb 23, 2022
Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation
Not yet recruiting
- Autosomal Dominant Optic Atrophy
- +3 more
-
Sydney, AustraliaSydney Eye Hospital
Nov 15, 2023
RESting-state Functional MRI in Optic Neuritis for ANticipation
Recruiting
- Neuritis
- MRI
- visual acuity
-
Paris, FranceFondation A De Rothschild
Mar 18, 2022
Multiple Sclerosis Trial in San Francisco, Cleveland (Multiple Sclerosis Clinical Care Delivery via telehealth, Multiple
Not yet recruiting
- Multiple Sclerosis
- Multiple Sclerosis Clinical Care Delivery via telehealth
- Multiple Sclerosis Clinical Care Delivery via standard in clinic visits
-
San Francisco, California
- +1 more
Jan 3, 2023
Central Visual Impairment Trial (Training of perception and oculo-motor control)
Not yet recruiting
- Central Visual Impairment
- Training of perception and oculo-motor control
- (no location specified)
Nov 24, 2022
Study of Retinal Dystrophies Associated With Rare
Active, not recruiting
- Inherited Retinal Degeneration
- Retinitis Pigmentosa
-
Phoenix, Arizona
- +23 more
Jan 24, 2023
Relapsing Remitting Multiple Sclerosis Trial in Dallas (gold nanocrystals)
Recruiting
- Relapsing Remitting Multiple Sclerosis
- gold nanocrystals
-
Dallas, TexasUniversity of Texas Southwestern
Jan 11, 2022
Age-Related Macular Degeneration Trial in United States (Iptacopan (LNP023), Placebo)
Recruiting
- Age-Related Macular Degeneration
- Iptacopan (LNP023)
- Placebo
-
Sacramento, California
- +9 more
Sep 20, 2022
Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells, Mock injection)
Completed
- Retinitis Pigmentosa
- human retinal progenitor cells
- Mock injection
-
Irvine, California
- +2 more
Mar 3, 2022
Visual Acuity Trial in Memphis (Toric Multifocal etafilcon A with PVP)
Completed
- Visual Acuity
- Toric Multifocal etafilcon A with PVP
-
Memphis, TennesseeTotal Eye Care PA
Feb 16, 2022
Eye Movement Rehabilitation in Low Vision Patients
Recruiting
- Low Vision
- Age Related Macular Degeneration
- Visual Feedback
-
Boston, Massachusetts
- +1 more
Jun 10, 2021
Dim Light Vision Disturbances Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution
Completed
- Dim Light Vision Disturbances
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle (Placebo)
-
Newport Beach, California
- +16 more
May 20, 2022
Friedreich Ataxia Trial in Worldwide
Recruiting
- Friedreich Ataxia
-
Los Angeles, California
- +13 more
Aug 23, 2023
Visual Acuity Trial in United States (ACUVUE Oasys 1-Day with HydraLuxe Technology for Astigmatism, ACUVUE Oasys 1-Day with
Completed
- Visual Acuity
- ACUVUE Oasys 1-Day with HydraLuxe Technology for Astigmatism
- ACUVUE Oasys 1-Day with HydraLuxe Technology
-
Rocklin, California
- +12 more
Mar 21, 2022